{"nctId":"NCT00273052","briefTitle":"COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension","startDateStruct":{"date":"2006-01-05"},"conditions":["Hypertension"],"count":514,"armGroups":[{"label":"Carvedilol Phosphate modified release formulation","type":"EXPERIMENTAL","interventionNames":["Drug: Carvedilol Phosphate modified release formulation"]},{"label":"metoprolol succinate","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: metoprolol succinate"]}],"interventions":[{"name":"Carvedilol Phosphate modified release formulation","otherNames":[]},{"name":"metoprolol succinate","otherNames":["Carvedilol Phosphate modified release formulation"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Documented history of hypertension\n* Triglycerides of 120-400 mg/mL\n* LDLc levels not requiring lipid lowering medication.\n\nExclusion Criteria:\n\n* Has known contraindication to alpha- or beta-blocker therapy.\n* Has taken any non-ocular beta-blockers within three months before screening.\n* Has Type I or II diabetes.\n* Taking lipid lowering medications.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Triglycerides Levels by Treatment Group at Maintenance Month 6","description":"Blood draw for triglyceride levels. Full beta quantification test performed which uses ultracentrifugation to partially separate lipoprotein classes and is the basis for the reference methods. Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.65","spread":null},{"groupId":"OG001","value":"10.39","spread":null}]}]}]},{"type":"PRIMARY","title":"Change From Baseline in High-Density Lipoprotein Cholesterol (HDL-C) Levels by Treatment Group at Maintenance Month 6","description":"Blood draw for HDL-C levels. Full beta Quant test performed with HDL subclasses. Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.4","spread":null},{"groupId":"OG001","value":"-5.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Log Transformed High Sensitivity C-reactive Protein (Hs-CRP) by Treatment Group at Maintenance Month 6","description":"Blood draw for hs-CRP. Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.76","spread":null},{"groupId":"OG001","value":"0.49","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Log Transformed Lipoprotein-associated Phospholipase A2 (LpPLA2) by Treatment Group at Maintenance Month 6","description":"Blood draw for LpPLA2 activity. Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.38","spread":null},{"groupId":"OG001","value":"-2.23","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Blood Pressure by Treatment Group at Maintenance Month 6","description":"Manual physical examination (cuff blood pressure). Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.90","spread":null},{"groupId":"OG001","value":"-16.23","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.89","spread":null},{"groupId":"OG001","value":"-11.06","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Heart Rate by Treatment Group at Maintenance Month 6","description":"Manual physical examination. Change = Month 6 value minus Baseline value. (BPM=beats per minute)","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.98","spread":null},{"groupId":"OG001","value":"-6.07","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Weight by Treatment Group at Maintenance Month","description":"Manual physical examination. Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.01","spread":null},{"groupId":"OG001","value":"0.73","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Additional Lipid Parameters by Treatment Group With Unit of Measures of mg/dL at Maintenance Month 6","description":"Blood draw for lipid levels. Full beta Quant test performed with HDL subclasses and IDL. IDL=Intermediate density lipoproteins, LDL=Low-density lipoprotein, VLDL=Very Low density lipoprotein, HDL=High-density lipoprotein. Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":null},{"groupId":"OG001","value":"-0.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.1","spread":null},{"groupId":"OG001","value":"-1.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":null},{"groupId":"OG001","value":"0.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.45","spread":null},{"groupId":"OG001","value":"-6.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.0","spread":null},{"groupId":"OG001","value":"-3.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.166","spread":null},{"groupId":"OG001","value":"-1.360","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":null},{"groupId":"OG001","value":"5.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Additional Lipid Parameters by Treatment Group With Unit of Measures of g/L at Maintenance Month 6","description":"Blood draw for lipid levels. Full beta Quant test performed. Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.82","spread":null},{"groupId":"OG001","value":"-3.45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.16","spread":null},{"groupId":"OG001","value":"0.81","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Insulin (Glycemic Parameter) by Treatment Group at Maintenance Month 6","description":"Blood draw for glycemia levels. Full beta Quant test performed. Test for Fasting plasma glucose, HbA1c, fasting insulin. Homeostasis model Assessment (HOMA) is a computer-generated model consisting of non-linear empirical equations solved numerically to predict glucose, Insulin and C-peptide concentrations in fasting subjects for insulin sensitivity (%S). Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.21","spread":null},{"groupId":"OG001","value":"1.35","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Hemoglobin A1c (HbA1c) (Glycemic Parameter) by Treatment Group at Maintenance Month 6","description":"Blood draw for glycemia levels. Full beta Quant test performed. Test for Fasting plasma glucose, HbA1c, fasting insulin. Homeostasis model Assessment (HOMA) is a computer-generated model consisting of non-linear empirical equations solved numerically to predict glucose, Insulin and C-peptide concentrations in fasting subjects for insulin sensitivity (%S). Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.01","spread":null},{"groupId":"OG001","value":"0.04","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in c-Peptide (Glycemic Parameter) by Treatment Group at Maintenance Month 6","description":"Blood draw for glycemia levels. Full beta Quant test performed. Test for Fasting plasma glucose, HbA1c, fasting insulin. Homeostasis model Assessment (HOMA) is a computer-generated model consisting of non-linear empirical equations solved numerically to predict glucose, Insulin and C-peptide concentrations in fasting subjects for insulin sensitivity (%S). Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.23","spread":null},{"groupId":"OG001","value":"0.20","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Homeostasis Model Assessment (Glycemic Parameter) by Treatment Group at Maintenance Month 6","description":"Blood draw for glycemia levels. Full beta Quant test performed. Test for Fasting plasma glucose, HbA1c, fasting insulin. Homeostasis model Assessment (HOMA) is a computer-generated model consisting of non-linear empirical equations solved numerically to predict glucose, Insulin and C-peptide concentrations in fasting subjects for insulin sensitivity (%S). Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.05","spread":null},{"groupId":"OG001","value":"-4.14","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Plasma Glucose (FPG) (Glycemic Parameter) by Treatment Group at Maintenance Month 6","description":"Blood draw for glycemia levels. Full beta Quant test performed. Test for Fasting plasma glucose, HbA1c, fasting insulin. Homeostasis model Assessment (HOMA) is a computer-generated model consisting of non-linear empirical equations solved numerically to predict glucose, Insulin and C-peptide concentrations in fasting subjects for insulin sensitivity (%S). Change = Month 6 value minus Baseline value.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.94","spread":null},{"groupId":"OG001","value":"1.20","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":8},"commonTop":["Headache","Edema Peripheral","Fatigue","Dizziness","Nasopharyngitis"]}}}